Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Clark

Showing results (1-10 of 239) with videos related to

Pageof 24
Sort By:
Biologics : Targets & Therapy|August 18, 2010
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinomaPeter E Clark
Current Opinion in Urology|September 1, 2007
Recent advances in targeted therapy for renal cell carcinomaPeter E Clark
The Journal of Urology|March 13, 2024
Peter E. Clark, MDPeter E Clark
Urology|July 26, 2020
EDITORIAL COMMENTPeter E Clark
European Urology|February 26, 2026
Re: Durvalumab in combination with BCG for BCG-naive, high risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trialPeter E Clark
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2015
Toward Personalized Guidelines in Bladder CancerPeter E Clark
Cancer|August 28, 2007
Upper tract transitional cell carcinoma: finding a way forwardPeter E Clark
The Journal of Urology|February 16, 2018
Editorial CommentPeter E Clark
Current Treatment Options in Oncology|August 27, 2002
Urinary diversion after radical cystectomyPeter E Clark
Current Opinion in Oncology|April 7, 2007
Bladder cancerPeter E Clark
Pageof 24

Showing results (1-10 of 239) with videos related to

Sort By:
Pageof 24
Biologics : Targets & Therapy|August 18, 2010
Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinomaPeter E Clark
Current Opinion in Urology|September 1, 2007
Recent advances in targeted therapy for renal cell carcinomaPeter E Clark
The Journal of Urology|March 13, 2024
Peter E. Clark, MDPeter E Clark
Urology|July 26, 2020
EDITORIAL COMMENTPeter E Clark
European Urology|February 26, 2026
Re: Durvalumab in combination with BCG for BCG-naive, high risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trialPeter E Clark
Journal of the National Comprehensive Cancer Network : JNCCN|December 15, 2015
Toward Personalized Guidelines in Bladder CancerPeter E Clark
Cancer|August 28, 2007
Upper tract transitional cell carcinoma: finding a way forwardPeter E Clark
The Journal of Urology|February 16, 2018
Editorial CommentPeter E Clark
Current Treatment Options in Oncology|August 27, 2002
Urinary diversion after radical cystectomyPeter E Clark
Current Opinion in Oncology|April 7, 2007
Bladder cancerPeter E Clark
Pageof 24